e-Article
Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic
Document Type
Article
Author
Source
In Respiratory Medicine and Research June 2023 83
Subject
Language
ISSN
2590-0412